Farmson Basic Drugs Opens ₹300 Crore Acetic Anhydride Manufacturing Facility in Vadodara

Farmson Basic Drugs has inaugurated a new ₹300 crore manufacturing facility in Nandesari, Vadodara, Gujarat. The Unit-VI facility is designed to produce acetic anhydride and marks a significant step in the company’s efforts to become a fully integrated producer of paracetamol. This expansion represents a major milestone for Farmson as it continues to enhance its production capabilities and strengthen its position in the pharmaceutical industry.

The state-of-the-art facility is located within the industrial hub of Vadodara and is equipped with advanced technology aimed at optimizing production efficiency. Acetic anhydride, a key raw material used in the synthesis of paracetamol, will be produced at this site, enabling Farmson to streamline its supply chain and reduce dependency on external suppliers. The investment underscores the company’s commitment to expanding its operations while maintaining high standards of quality and sustainability.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 7, 2025

Related posts:

Drug Patent Strategies: Monitoring Disputes, Compliance, and Patent Filing Timing Becoming Key for Pharma Companies Harvard Researcher Scott Delaney Documents 2,100 NIH Grant Terminations Before Losing His Own Funding FDA Accepts New Drug Application for Vepdegestrant, a Breast Cancer Treatment Developed by Arvinas and Pfizer Study Explores Factors Influencing Early-Career Doctors to Choose Rural Practice Over Urban

Author

GOAI